loe 908 has been researched along with bucladesine in 1 studies
| Studies (loe 908) | Trials (loe 908) | Recent Studies (post-2010) (loe 908) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
|---|---|---|---|---|---|
| 50 | 0 | 5 | 9,775 | 13 | 210 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndts, D; Hammer, R; Hescheler, J; Krautwurst, D; Lösel, W; Schultz, G | 1 |
1 other study(ies) available for loe 908 and bucladesine
| Article | Year |
|---|---|
Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.
Topics: Acetamides; Adenosine Triphosphate; Bucladesine; Cations; Cell Differentiation; Electrophysiology; Humans; Ion Channels; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tumor Cells, Cultured | 1993 |